Company: RPTX
Filing Date: 2025-12-03
Form Type: PREM14A
Source: 0001193125-25-306948
Chunk: 68

Company: Repare Therapeutics Inc.
Filing Date: 2025-12-03
Form: PREM14A
Chunk 68
---
 subject to the various assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, the Cash Consideration proposed to be paid to the holders of Common Shares (other than Excluded Shares) pursuant to the terms of the Arrangement was fair, from a financial point of view, to such holders. 38

The full text of the written opinion of Leerink Partners, dated November 14, 2025, which describes the assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion, is attached as Annex B and is incorporated herein by reference. The summary of the written opinion of Leerink Partners set forth below is qualified in its entirety by the full text of the written opinion attached hereto as Annex B. Leerink Partners’ financial advisory services and opinion were provided for the information and assistance of the Transaction Committee and the Repare Board (in their capacity as directors and not in any other capacity) in connection with and for purposes of their consideration of the Transaction and the opinion of Leerink Partners addressed only the fairness, from a financial point of view, as of the date thereof, to the holders of Common Shares (other than Excluded Shares) of the Cash Consideration proposed to be paid to such holders pursuant to the Arrangement. The opinion of Leerink Partners did not address any other term or aspect of the Agreement or the Transaction and does not constitute a recommendation to any shareholder of Repare as to whether or how such holder should vote with respect to the Transaction or otherwise act with respect to the Agreement or any other matter. The full text of the written opinion of Leerink Partners should be read carefully in its entirety for a description of the assumptions made, and the qualifications and limitations upon the review undertaken by Leerink Partners in preparing its opinion. In connection with rendering the opinion described above and performing its related financial analyses, Leerink Partners reviewed, among other things:

| • |     | certain Current Reports on Form 8-K, as filed by Repare with, or 
 furnished by Repare to, the SEC; and                             |

| • |     | a dissolution analysis of Repare, as furnished to Leerink Partners by the management of Repare and approved by                          
 management for use by Leerink Partners, which is referred to in this summary of Leerink Partners’ opinion as the “Dissolution Analysis” |

Leerink Partners also conducted discussions with members of the senior management and representatives of Repare regarding such Dissolution Analysis. Rep